دورية أكاديمية
GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location.
العنوان: | GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location. |
---|---|
المؤلفون: | De Souza Albuquerque MS; Universidade Federal de Pernambuco. marioalbuquerque91@gmail.com., Da Silva-Filho AF, Ferraz Cordeiro M, Deodato de Souza MF, Quirino MWL, Amorim Lima LR, Da Rocha Pitta MG, Martins MR, De Melo Rêgo MJB |
المصدر: | European journal of histochemistry : EJH [Eur J Histochem] 2018 Jun 14; Vol. 62 (2), pp. 2931. Date of Electronic Publication: 2018 Jun 14. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: PagePress Publications Country of Publication: Italy NLM ID: 9207930 Publication Model: Electronic Cited Medium: Internet ISSN: 2038-8306 (Electronic) Linking ISSN: 1121760X NLM ISO Abbreviation: Eur J Histochem Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Jan. 2010- : Pavia : PagePress Publications Original Publication: Pavia : Luigi Ponzio, [1992- |
مواضيع طبية MeSH: | Adenocarcinoma/*enzymology , Adenocarcinoma/*pathology , Immunohistochemistry/*methods , N-Acetylgalactosaminyltransferases/*metabolism , Stomach Neoplasms/*enzymology , Stomach Neoplasms/*pathology, Adenocarcinoma/surgery ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Female ; Gastrectomy ; Humans ; Male ; Middle Aged ; Prognosis ; Stomach Neoplasms/surgery ; Polypeptide N-acetylgalactosaminyltransferase |
مستخلص: | Gastric cancer (GC) is the second most common cause of cancer-related deaths in the world. This study aims to investigate the differential tissue expression of ppGalNAc-T15 and to evaluate its possible association with clinical-pathological parameters and outcome of gastric adenocarcinoma patients. For these 70 patients were evaluated the expression by immunohistochemistry to ppGalNAc-T15. Our results showed that 33 (47.1%) patients were ppGalNAC-T15+ positive and 37 (52.9%) negative. Positive staining for ppGalNAc-T15 was significantly present in patients older than 60 years (P=0.0306) and submitted to total gastrectomy (P=0.0087). Also, some results remained at the limit of significance as surgical standing (P=0.0562) and histological grade (P=0.0549). Therefore, the ppGalNAc-T15 immunoreactivity can be useful to understand the prognosis of patients with gastric cancer. |
References: | World J Gastroenterol. 2014 Feb 21;20(7):1667-80. (PMID: 24587646) J Gastroenterol Hepatol. 2010 Mar;25(3):512-8. (PMID: 20370729) Cell Physiol Biochem. 2017;41(5):1801-1829. (PMID: 28376491) Oncotarget. 2016 Mar 8;7(10):11251-62. (PMID: 26848976) Proteomics Clin Appl. 2013 Oct;7(9-10):618-31. (PMID: 23857728) Cancer. 2002 Apr 1;94(7):1939-46. (PMID: 11932895) Cancer Res. 2008 Sep 15;68(18):7313-22. (PMID: 18794118) FEBS Lett. 2004 May 21;566(1-3):17-24. (PMID: 15147861) Cancer Biol Ther. 2009 Apr;8(7):6-15. (PMID: 19417560) Glycobiology. 2012 Jun;22(6):736-56. (PMID: 22183981) Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13. (PMID: 24618998) J Cell Biol. 2010 May 31;189(5):843-58. (PMID: 20498016) EMBO Rep. 2006 Jun;7(6):599-604. (PMID: 16741504) Cancer Manag Res. 2018 Feb 07;10:239-248. (PMID: 29445300) Biomolecules. 2016 Jul 11;6(3):. (PMID: 27409642) Cancer. 1993 Dec 15;72(12):3641-7. (PMID: 8252480) Cancer. 1990 Nov 1;66(9):1960-6. (PMID: 2224793) |
فهرسة مساهمة: | Keywords: Gastric adenocarcinoma; clinical-pathological analyses; immunohistochemistry.; polypeptide N-acetylgalactosaminyltransferases |
المشرفين على المادة: | EC 2.4.1.- (N-Acetylgalactosaminyltransferases) |
تواريخ الأحداث: | Date Created: 20180627 Date Completed: 20181029 Latest Revision: 20231213 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC6038116 |
DOI: | 10.4081/ejh.2018.2931 |
PMID: | 29943957 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2038-8306 |
---|---|
DOI: | 10.4081/ejh.2018.2931 |